Globe Life Inc.
$151.65-$1.94 (-1.3%)
Last close · Data as of Nov 20, 2026
- Market cap
- $12.0B
- P/E
- 10.3x
- Revenue
- $6.0B
- Net margin
- 19.4%
- ROCE
- 18.3%
Price chart
Technical chartScreen technicals →+16.3% over the last year
Daily closes.
Go deeper
Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes
Performance
Price return, before dividends, to the 20 Nov 2026 close.
- 1M
- -10.6%
- 3M
- -11.1%
- 6M
- -1.8%
- 1Y
- +16.3%
- 5Y
- Hidden
- This period includes a one-day price step on 11 Apr 2024 that looks like a share split or a similar corporate action. The figure is hidden until the price history is adjusted for it.
52-week range
Day change -$1.94 (-1.3%) from $154 to $152 · Last close Nov 20, 2026
Best weekday to invest, historically
The same weekly amount in GL, bought on each weekday since 2021.
News & filings
What Globe Life filed, who traded, and what's next
How to read this
"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.
AI Summary
US StockStrengthReturn on equity of 19.4% against a peer median of 9.4%.
Concerns (1)
- Revenue grew 4.7% a year over three years.
Prices to the 20 Nov 2026 close · Financial year: fiscal 2025
Rule-based from financial data. Not advice.
About the company
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products to lower middle- and middle-income families in the United States. It operates in three segments: Life Insurance, Supplemental Health Insurance, and Investments.
Read moreShow less
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products to lower middle- and middle-income families in the United States. It operates in three segments: Life Insurance, Supplemental Health Insurance, and Investments. The company offers whole, term, and other life insurance products, as well as life insurance for children; Medicare supplement and limited-benefit supplemental health insurance products, such as accident, cancer, critical illness, heart, intensive care, and other health products; and final expense, accidental death, mortgage protection, and hospital insurance products. It sells its products through direct-to-consumer channels, exclusive independent agents, general agency independent agents, and brokers. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was founded in 1900 and is headquartered in McKinney, Texas.
- Sector
- Financial Services
- Shares outstanding
- 81.4M
Key statistics
Screen fundamentals →Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.
Valuation
- Market cap
- $12.0B
- P/E
- 10.3x
- P/B
- 2.0x
- EV / Sales
- 2.4x
- P/S
- 2.0x
- 52-week high
- $186.02
- 52-week low
- $130.37
Profitability
- Operating margin
- 26.3%
- Net margin
- 19.4%
- ROE
- 19.4%
- ROCE
- 18.3%
- ROA
- 3.8%
- Asset turnover
- 0.19
Growth
- RevenueFY2025, the latest fiscal year in the company's growth history.
- $6.0B
- Revenue growth, 1YFY2025, the latest fiscal year in the company's growth history.
- 3.7%
- Revenue CAGR, 3YFY2025, the latest fiscal year in the company's growth history.
- 4.7%
- Net profit growth, 1YFY2025, the latest fiscal year in the company's growth history.
- 8.4%
- Free cash flowFY2025, the latest fiscal year in the company's growth history.
- $1.3B
Solvency
- Debt / Equity
- 0.44
- Debt / Assets
- 0.09
- CFO / Net profit
- 1.20
- Cash / Market cap
- 1.2%
Where the revenue went
Some FY2025 lines are not reported, so the ones that are appear as a table.
| Line | FY2025 |
|---|---|
| Revenue | $6.0B |
| Gross profit | $6.0B |
| Operating expenses | — |
| Selling, general and administrative | $408.9M |
| Pretax income | $1.4B |
| Tax and other | $274.7M |
| Net income | $1.2B |
Revenue and net profit
Revenue grew 3.7% in FY2025; net profit is the dashed line.
| Date | Revenue | Net profit |
|---|---|---|
| FY2022 | $5.2B | $894.4M |
| FY2023 | $5.4B | $970.8M |
| FY2024 | $5.8B | $1.1B |
| FY2025 | $6.0B | $1.2B |
Cash flows
FY2025: $1.4B from operations, $1.3B free after investment (dashed).
| Date | Operating cash flow | Free cash flow |
|---|---|---|
| FY2022 | $1.4B | $1.4B |
| FY2023 | $1.5B | $1.4B |
| FY2024 | $1.4B | $1.3B |
| FY2025 | $1.4B | $1.3B |
Growth
Latest fiscal year 2025: each figure with its change over the year before.
- Revenue
- $6.0B+3.7%1Y
- Net profit
- $1.2B+8.4%1Y
- Cash from operations
- $1.4B-0.4%1Y
- Free cash flow
- $1.3B-5.8%1Y
- Revenue CAGR, 3Y
- 4.7%
- Net profit CAGR, 3Y
- 9.1%
| Year | Revenue | EBITDA | Net profit | FCF | ROE | Revenue growth 1Y | Net profit growth 1Y |
|---|---|---|---|---|---|---|---|
| FY2025 | $6.0B | — | $1.2B | $1.3B | 19.4% | +3.7% | +8.4% |
Monthly returns
Month-by-month returns of GL across the years, with the seasonal pattern.
Balance sheet
What the company owns and owes at the end of FY2025.
| Line | FY2025 |
|---|---|
| Assets | $30.8B |
| Current assets | — |
| Non-current assets | — |
| Liabilities | $24.8B |
| Current liabilities | — |
| Non-current liabilities | — |
| Equity | $6.0B |
| Paid-in capital | $536.4M |
| Retained earnings | $8.5B |
| Treasury stock | $1.4B |
Market cap against peers
8 peers: same sector, nearest by size.
Peers map
Financial Services companies placed by value, growth and quality; GL highlighted.
P/E against peers
GL trades at 10.3x earnings against a peer median of 16.5x (a 37% discount).
Not shown (no positive earnings and no EV / Sales): Invesco Ltd.
Peer comparison
Same-sector peers by market cap, with the median.
| Company | Market cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|
| Globe Life Inc.GLthis companyP/E ↓ discount | $12.0B | 10.3x | 2.0x | 19.4% | — |
| Principal Financial Group, Inc.PFG | $22.4B | 18.9x | 1.9x | 10.0% | — |
| Loews CorporationL | $21.6B | 13.0x | 1.2x | 8.9% | — |
| Brown & Brown, Inc.BRO | $19.4B | 18.6x | 1.6x | 8.3% | 12.9x |
| Franklin Resources, Inc.BEN | $16.6B | 31.6x | 1.4x | 4.3% | 18.6x |
| Everest Group, Ltd.EG | $12.6B | 7.9x | 0.8x | 10.3% | — |
| Invesco Ltd.IVZ | $12.5B | -44.3x | 1.3x | -2.9% | 13.2x |
| Assurant, Inc.AIZ | $12.5B | 14.3x | 2.1x | 14.9% | — |
| Erie Indemnity CompanyERIE | $11.5B | 20.5x | 5.0x | 24.5% | — |
| Peer median | — | 16.5x | 1.5x | 9.4% | 13.2x |
Year-to-date ROI
GL since 1 January, against earlier years.
Historical volatility
GL's day-to-day swings over 30, 60 and 180 days.
Financial statements
Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.
Consolidated figures in USD, fiscal years, newest first.
| Line | FY2025 |
|---|---|
| RevenueTotal Revenue | $6.0B |
| Operating expenses | |
| Selling, general and administrativeSelling General And Administration | $408.9M |
| Other operating expensesOther Operating Expenses | $16.4M |
| Total expensesTotal Expenses | $4.6B |
| Interest and other | |
| Pretax incomePretax Income | $1.4B |
| TaxTax Provision | $274.7M |
| Net incomeNet Income | $1.2B |
| Per share | |
| Supplementary | |
| Other lines |
| Line | FY2025 |
|---|---|
| AssetsTotal Assets | $30.8B |
| Current assets | |
| Non-current assets | |
| LiabilitiesTotal Liabilities Net Minority Interest | $24.8B |
| Current liabilities | |
| Non-current liabilities | |
| EquityTotal Equity Gross Minority Interest | $6.0B |
| Supplementary |
| Line | FY2025 |
|---|---|
| Operating cash flowOperating Cash Flow | $1.4B |
| Cash from continuing operationsCash Flow From Continuing Operating Activities | $1.4B |
| Net income, continuing operationsNet Income From Continuing Operations | $1.2B |
| Amortization of securitiesAmortization Of Securities | -$494.2M |
| Operating gains and lossesOperating Gains Losses | $27.8M |
| Gain loss on investment securitiesGain Loss On Investment Securities | $27.8M |
| Change in working capitalChange In Working Capital | $702.1M |
| Other non-cash itemsOther Non Cash Items | -$620.0k |
| Cash from discontinued operating activitiesCash From Discontinued Operating Activities | — |
| Investing cash flowInvesting Cash Flow | -$643.6M |
| Cash from continuing investingCash Flow From Continuing Investing Activities | -$643.6M |
| Capital expenditureCapital Expenditure | -$142.5M |
| Purchase of PP&EPurchase Of PPE | -$142.5M |
| Net PP&E purchases and salesNet PPE Purchase And Sale | -$142.5M |
| Purchase of investmentsPurchase Of Investment | -$1.5B |
| Sale of investmentsSale Of Investment | $1.1B |
| Net investment purchases and salesNet Investment Purchase And Sale | -$385.3M |
| Other investing changesNet Other Investing Changes | — |
| Financing cash flowFinancing Cash Flow | -$768.0M |
| Cash from continuing financingCash Flow From Continuing Financing Activities | -$768.0M |
| Debt issuedIssuance Of Debt | $590.3M |
| Debt repaidRepayment Of Debt | -$701.0M |
| Net debt issuedNet Issuance Payments Of Debt | -$110.7M |
| Short-term debt issuedShort Term Debt Issuance | $590.3M |
| Short-term debt repaidShort Term Debt Payments | -$701.0M |
| Net short-term debt issuedNet Short Term Debt Issuance | -$110.7M |
| Long-term debt issuedLong Term Debt Issuance | $0.00 |
| Long-term debt repaidLong Term Debt Payments | $0.00 |
| Net long-term debt issuedNet Long Term Debt Issuance | — |
| Shares issuedIssuance Of Capital Stock | $164.4M |
| Common stock issuedCommon Stock Issuance | $164.4M |
| Net common stock issuedNet Common Stock Issuance | -$716.5M |
| Common stock repurchasedCommon Stock Payments | -$881.0M |
| Share buybacksRepurchase Of Capital Stock | -$881.0M |
| Dividends paidCash Dividends Paid | -$86.1M |
| Common dividends paidCommon Stock Dividend Paid | -$86.1M |
| Other financing chargesNet Other Financing Charges | $145.3M |
| Change in cashChanges In Cash | -$15.3M |
| Effect of exchange ratesEffect Of Exchange Rate Changes | -534.0% |
| Cash at the start of the yearBeginning Cash Position | $165.3M |
| Cash at the end of the yearEnd Cash Position | $144.7M |
| Free cash flowFree Cash Flow | $1.3B |
| Supplemental |
Learn while you research
Academy chapters picked for Globe Life Inc. and the metrics on this page.
- 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
- 02 Value InvestingA P/E of 10.3 could be a value opportunity, or a value trap. Know the difference.7 min read
- 03 Sector AnalysisBanks & financials are uniquely sensitive to rates and credit cycles.6 min read
- 04 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
- 05 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read